Trademark search
The 50 closest matches for of record for one firm.
| Mark | Status | Office | Owner | Classes | Filed |
|---|---|---|---|---|---|
| COBENFYCAST | examining | USPTO | Karuna Therapeutics, Inc. | 9, 41 | 2026-10-08 |
| WELKARZO | examining | USPTO | Juno Therapeutics, Inc. | 5 | 2026-09-24 |
| COBENFYCAST | examining | USPTO | Karuna Therapeutics, Inc. | 9, 41 | 2026-09-11 |
| HYJURNY | examining | USPTO | Bristol-Myers Squibb Company | 5 | 2026-09-03 |
| HYOPZIG | examining | USPTO | Bristol-Myers Squibb Company | 5 | 2026-09-03 |
| SURHYLA | examining | USPTO | Bristol-Myers Squibb Company | 5 | 2026-09-03 |
| REPTYROS | examining | USPTO | Turning Point Therapeutics, Inc. | 5 | 2026-09-03 |
| LEVCYFI | examining | USPTO | Bristol-Myers Squibb Company | 5 | 2026-07-29 |
| TEUVIJOY | pending opposition | USPTO | Bristol-Myers Squibb Company | 5 | 2026-07-24 |
| TYKDEUVY | pending opposition | USPTO | Bristol-Myers Squibb Company | 5 | 2026-07-24 |
| TEUVIJOI | pending opposition | USPTO | Bristol-Myers Squibb Company | 5 | 2026-07-24 |
| BRAIN HEALTH IS HEALTH | pending opposition | USPTO | Bristol-Myers Squibb Company | 5, 44 | 2026-07-23 |
| RYZEWELVO | examining | USPTO | Juno Therapeutics, Inc. | 5 | 2026-07-16 |
| WELQARZO | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-07-16 |
| RYZEWELZI | examining | USPTO | Juno Therapeutics, Inc. | 5 | 2026-07-16 |
| WELCARZO | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-07-16 |
| WELCARYO | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-07-16 |
| ZOLCARTIQ | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-07-16 |
| AUVAMTRI | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-07-10 |
| AUVIMSEO | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-07-10 |
| BRAVUPDA | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-07-10 |
| BRYZOLDIV | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-07-10 |
| CARTZOVY | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-07-10 |
| RYZEWELBI | examining | USPTO | Juno Therapeutics, Inc. | 5 | 2026-07-10 |
| TAYZELGO | examining | USPTO | Bristol-Myers Squibb Company | 5 | 2026-06-24 |
| PLYFCI | examining | USPTO | Bristol-Myers Squibb Company | 5 | 2026-06-24 |
| TAYZELGA | examining | USPTO | Bristol-Myers Squibb Company | 5 | 2026-06-24 |
| GRELFAZ | examining | USPTO | Bristol-Myers Squibb Company | 5 | 2026-06-24 |
| FUSELPA | examining | USPTO | Bristol-Myers Squibb Company | 5 | 2026-06-24 |
| DAZFANA | examining | USPTO | Bristol-Myers Squibb Company | 5 | 2026-06-24 |
| WELZOQAR | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-06-15 |
| NIMMUCARTZ | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-06-15 |
| KARZOLV | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-06-15 |
| BRYZUPTI | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-06-15 |
| AUTIMMCA | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-06-15 |
| ANZECARTZ | pending opposition | USPTO | Juno Therapeutics, Inc. | 5 | 2026-06-15 |
| ONXARVIQ | examining | USPTO | Celgene Corporation | 5 | 2026-06-08 |
| ONZARVIQ | examining | USPTO | Celgene Corporation | 5 | 2026-06-08 |
| ORDEGRIA | examining | USPTO | Celgene Corporation | 5 | 2026-06-08 |
| REYXARGO | examining | USPTO | Celgene Corporation | 5 | 2026-06-08 |
| TREVRAYO | examining | USPTO | Celgene Corporation | 5 | 2026-06-08 |
| VOZDEGRA | examining | USPTO | Celgene Corporation | 5 | 2026-06-08 |
| XEBRYAR | examining | USPTO | Celgene Corporation | 5 | 2026-06-08 |
| DEYDESGO | examining | USPTO | Celgene Corporation | 5 | 2026-06-08 |
| DEGARVI | examining | USPTO | Celgene Corporation | 5 | 2026-06-08 |
| ARZODUA | examining | USPTO | Celgene Corporation | 5 | 2026-06-08 |
| ARXELDUA | pending publication | USPTO | Celgene Corporation | 5 | 2026-06-08 |
| ARTREYVO | pending publication | USPTO | Celgene Corporation | 5 | 2026-06-08 |
| ARMARXI | pending publication | USPTO | Celgene Corporation | 5 | 2026-06-08 |
| ARDEGVI | pending publication | USPTO | Celgene Corporation | 5 | 2026-06-08 |